Abstract:Background and aim: COVID-19, the infectious disease caused by SARS-CoV-2 virus that has been causing a severe pandemic worldwide for more than 2 years, is characterized by a high heterogeneity of clinical presentations and evolution and, particularly, by a varying severity of respiratory involvement. This study aimed to analyze the diversity and taxonomic composition of the gut microbiota at hospital admission, in order to evaluate its association with COVID-19 outcome. In particular, the association between gut microbiota and a combination of several clinical covariates was analyzed in order to characterize the bacterial signature associate to mild or severe symptoms during the SARS-CoV-2 infection. Materials and methods: V3–V4 hypervariable region of 16S rRNA gene sequencing of 97 rectal swabs from a retrospective cohort of COVID-19 hospitalized patients was employed to study the gut microbiota composition. Patients were divided in two groups according to their outcome considering the respiratory supports they needed during hospital stay: (i) group "mild," including 47 patients with a good prognosis and (ii) group "severe," including 50 patients who experienced a more severe disease due to severe respiratory distress that required non-invasive or invasive ventilation. Identification of the clusters of bacterial population between patients with mild or severe outcome was assessed by PEnalized LOgistic Regression Analysis (PELORA). Results: Although no changes for Chao1 and Shannon index were observed between the two groups a significant greater proportion of Campylobacterota and Actinobacteriota at phylum level was found in patients affected by SARS-CoV-2 infection who developed a more severe disease characterized by respiratory distress requiring invasive or non-invasive ventilation. Clusters have been identified with a useful early potential prognostic marker of the disease evolution. Discussion: Microorganisms residing within the gut of the patients at hospital admission, were able to significantly discriminate the clinical evolution of COVID-19 patients, in particular who will develop mild or severe respiratory involvement. Our data show that patients affected by SARS-CoV-2 with mild or severe symptoms display different gut microbiota profiles which can be exploited as potential prognostic biomarkers paving also the way to new integrative therapeutic approaches.

Gut microbiota composition is associated with disease severity and host immune responses in COVID-19

Gut Microbiota Improves Prognostic Prediction in Critically Ill COVID-19 Patients Alongside Immunological and Hematological Indicators

Integrated Analysis of Gut Microbiome and Host Immune Responses in COVID-19

Dynamics of the Upper Respiratory Tract Microbiota and Its Association with Fatality in COVID-19 Patients

Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19

Gut microbiome alterations and gut barrier dysfunction are associated with host immune homeostasis in COVID-19 patients

Gut Mycobiota Alterations in Patients with COVID-19 and H1N1 Infections and Their Associations with Clinical Features

Gut mycobiota alterations in patients with COVID-19 and H1N1 and associations with immune and gastrointestinal symptoms

Alterations of the Gut Microbiota in Patients with Coronavirus Disease 2019 or H1N1 Influenza.

Clinical Significance of the Correlation between Changes in the Major Intestinal Bacteria Species and COVID-19 Severity

The Faecal Metabolome in COVID-19 Patients is Altered and Associated with Clinical Features and Gut Microbes

Potential Associations Between Microbiome and COVID-19

Gut Microbiome Alterations in COVID-19

Association of Gut Microbiota with COVID-19 Susceptibility and Severity: A Two-Sample Mendelian Randomization Study.

Lymphocyte and neutrophil count combined with intestinal bacteria abundance predict the severity of COVID-19

Integrated gut virome and bacteriome dynamics in COVID-19 patients

The relationship between gut and nasopharyngeal microbiome composition can predict the severity of COVID-19

The relationship between gut microbiota and COVID-19 progression: new insights into immunopathogenesis and treatment

Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications

Gut microbiota composition in COVID-19 hospitalized patients with mild or severe symptoms

Fecal multi-omics analysis reveals diverse molecular alterations of gut ecosystem in COVID-19 patients